Clinical Trial Update: Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing Lexiscan (regadenoson)–based Rubidium-82 PET myocardial perfusion imaging with Dipyridamole stress in patients with coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Dipyridamole (Dipyridamole)
• Lexiscan (regadenoson)

Snippet

Sponsor: Cardiovascular Imaging Technologies | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN